Diseases & Conditions market research reports by GlobalData

• Soft Tissue Sarcoma: Competitive Landscape

  Jun 26, 2024  |  Published by: GlobalData  |  USD 3,495

  Soft Tissue Sarcoma: Competitive Landscape Soft Tissue Sarcoma: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in soft tissue sarcoma therapeutics. In 2024, more than 300,000 diagnosed prevalent cases of STS are anticipated ... Read More

• Dyslipidemia - Global Clinical Trials Review, 2024

  Jun 24, 2024  |  Published by: GlobalData  |  USD 3,450

  Dyslipidemia - Global Clinical Trials Review, 2024 Dyslipidemia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dyslipidemia - Global Clinical Trials Review, 2024"" provides an overview of Dyslipidemia Clinical trials scenario. This report provides top line data re ... Read More

• Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024

  Jun 24, 2024  |  Published by: GlobalData  |  USD 3,450

  Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024 Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024"" provides an overview of Primary Sjogren's Syndrome Clinica ... Read More

• Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024

  Jun 24, 2024  |  Published by: GlobalData  |  USD 3,450

  Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024 Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladde ... Read More

• Osteoporosis: Seven-Market Drug Forecast and Market Analysis

  Jun 24, 2024  |  Published by: GlobalData  |  USD 14,995

  Osteoporosis: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by ... Read More

• Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Jun 13, 2024  |  Published by: GlobalData  |  USD 4,000

  Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, ... Read More

• Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  Jun 11, 2024  |  Published by: GlobalData  |  USD 7,500

  Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics the ... Read More

• Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  May 31, 2024  |  Published by: GlobalData  |  USD 4,000

  Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulato ... Read More

• Diabetic Foot Ulcers - Global Clinical Trials Review, 2024

  May 28, 2024  |  Published by: GlobalData  |  USD 2,500

  Diabetic Foot Ulcers - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Diabetic Foot Ulcers - Global Clinical Trials Review, 2024" provides an overview of Diabetic Foot Ulcers Clinical trials scenario. This report provides top line data relating to the clinical tri ... Read More

• Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024

  May 28, 2024  |  Published by: GlobalData  |  USD 2,500

  Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials s ... Read More

• Gaucher Disease - Global Clinical Trials Review, 2024

  May 28, 2024  |  Published by: GlobalData  |  USD 2,500

  Gaucher Disease - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Gaucher Disease - Global Clinical Trials Review, 2024" provides an overview of Gaucher Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher ... Read More

• Genital Herpes: Competitive Landscape

  May 22, 2024  |  Published by: GlobalData  |  USD 3,495

  Genital Herpes: Competitive Landscape Genital Herpes: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in genital herpes therapeutics. In 2024, more than 52 million diagnosed prevalent cases of HSV-2 infection are anticipated ... Read More

• Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  May 14, 2024  |  Published by: GlobalData  |  USD 14,995

  Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Glucagon-Like Peptide 1 Receptor (GLP ... Read More

• Osteoporosis: Epidemiology Forecast to 2033

  May 08, 2024  |  Published by: GlobalData  |  USD 3,995

  Osteoporosis: Epidemiology Forecast to 2033 Summary Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a normal process known as remodeling, some of a person’s bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteopo ... Read More

• Key Trends in Business Travel (2024)

  May 08, 2024  |  Published by: GlobalData  |  USD 1,495

  Key Trends in Business Travel (2024) Summary Analysis of the business travel sector including insights in business travelers, market trends influenced by COVID-19, consumer trends, destinations, sector deals, challenges and opportunities. Key Highlights The overall outbound trips for business purpos ... Read More

• HER2-Positive Breast Cancer: Epidemiology Forecast to 2033

  May 02, 2024  |  Published by: GlobalData  |  USD 3,995

  HER2-Positive Breast Cancer: Epidemiology Forecast to 2033 Summary Breast cancer (International Classification of Diseases, 10th Revision [ICD-10] codes C50.0-50.9) is a malignant tumor that originates in the breast tissue. Breast cancer cells begin inside the milk ducts of the breast. The earliest ... Read More

• Sleep Apnea Diagnostic Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Apr 29, 2024  |  Published by: GlobalData  |  USD 4,000

  Sleep Apnea Diagnostic Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Sleep Apnea Diagnostic Systems Pipeline Report including Stages of Development, Segments ... Read More

• Post-operative Pain (POP) - Competitive Landscape

  Apr 25, 2024  |  Published by: GlobalData  |  USD 3,495

  Post-operative Pain (POP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in POP therapeutics. In 2024, more than 34,000,000 incident cases of POP are anticipated in the 16 countries covered in GlobalData’s epidemiology for ... Read More

• Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 provides an overview of Chronic Lymphocytic Leukemia (CLL) Clinical trials scenario. This report provides top ... Read More

• Mycosis Fungoides - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Mycosis Fungoides - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Mycosis Fungoides - Global Clinical Trials Review, 2024 provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical trials on Mycos ... Read More

• Epilepsy - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Epilepsy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Epilepsy - Global Clinical Trials Review, 2024 provides an overview of Epilepsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Epilepsy. Report includes an ove ... Read More

• Pulmonary Tuberculosis - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Pulmonary Tuberculosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Pulmonary Tuberculosis - Global Clinical Trials Review, 2024 provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical ... Read More

• Digital Marketing Trends in Type 2 Diabetes - April 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Type 2 Diabetes - April 2024 Summary Novo Nordisk’s Ozempic.com achieved the highest total traffic across branded type 2 diabetes (T2D) patient sites in the US, at 16,000,000 visitors from April 2023 to March 2024. This was followed by Rybelsus.com with over 9,000,000 vis ... Read More

• Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs

  Apr 19, 2024  |  Published by: GlobalData  |  USD 295

  Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More

• New Drug Approvals and Their Contract Manufacture - 2024 Edition

  Apr 16, 2024  |  Published by: GlobalData  |  USD 4,995

  New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >